NCT00660257: Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine |
|
|
| Completed | 1 | 57 | RoW | pandemic influenza vaccine (H5N1 strain NIBRG-14) | Sinovac Biotech Co., Ltd, Centers for Disease Control and Prevention, China | Pandemic Influenza Vaccine, Prevention, Pandemic Influenza | 03/07 | 03/08 | | |
